I agree eddie,at the worst it should hold the price where it is or maybe get back to between 5 and 6,6 maybe pushing it with the market the way it is.But who knows,i do feel it was more positive then negative news.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
